Israelitic Hospital, Academic Hospital University of Hamburg, Orchideenstieg 14, 22297 Hamburg, Germany.
University of Perugia, Piazza dell'Università, 1, 06121 Perugia, Italy.
Nat Rev Gastroenterol Hepatol. 2018 May;15(5):291-308. doi: 10.1038/nrgastro.2018.7. Epub 2018 Apr 6.
Disturbances of gastric, intestinal and colonic motor and sensory functions affect a large proportion of the population worldwide, impair quality of life and cause considerable health-care costs. Assessment of gastrointestinal motility in these patients can serve to establish diagnosis and to guide therapy. Major advances in diagnostic techniques during the past 5-10 years have led to this update about indications for and selection and performance of currently available tests. As symptoms have poor concordance with gastrointestinal motor dysfunction, clinical motility testing is indicated in patients in whom there is no evidence of causative mucosal or structural diseases such as inflammatory or malignant disease. Transit tests using radiopaque markers, scintigraphy, breath tests and wireless motility capsules are noninvasive. Other tests of gastrointestinal contractility or sensation usually require intubation, typically represent second-line investigations limited to patients with severe symptoms and are performed at only specialized centres. This Consensus Statement details recommended tests as well as useful clinical alternatives for investigation of gastric, small bowel and colonic motility. The article provides recommendations on how to classify gastrointestinal motor disorders on the basis of test results and describes how test results guide treatment decisions.
胃、肠和结肠运动和感觉功能障碍影响全球很大一部分人群,降低生活质量并导致大量医疗保健费用。对这些患者的胃肠道动力进行评估可用于确定诊断并指导治疗。在过去 5-10 年中,诊断技术的重大进展导致了这一更新,介绍了目前可用测试的适应证、选择和性能。由于症状与胃肠道运动功能障碍的一致性较差,因此在没有证据表明存在病因性黏膜或结构疾病(如炎症或恶性疾病)的情况下,应进行临床动力测试。使用不透射线标志物、闪烁扫描、呼吸测试和无线动力胶囊的转运测试是非侵入性的。其他胃肠道收缩性或感觉测试通常需要插管,通常代表二线调查,仅限于有严重症状的患者,并且仅在专门中心进行。本共识声明详细介绍了推荐的测试,以及用于研究胃、小肠和结肠动力的有用临床替代方法。本文还就如何根据测试结果对胃肠道运动障碍进行分类以及如何根据测试结果指导治疗决策提出了建议。